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questions for the first time. The aim of the present study was to test the inter-
rater reliability of PANSS-6 ratings obtained using the SNAPSI.
Methods: The team of raters (five medical doctors and two psychologists) 
attended training sessions prior to the inter-rater reliability test. At the 
training sessions one rater interviewed a patient with schizophrenia using 
the SNAPSI, while all raters conducted PANSS-6 ratings independently. 
After each interview the PANSS-6 ratings were discussed until an agree-
ment was reached. Each rater participated in at least six SNAPSI/PANSS-6 
training ratings.
For the inter-rater reliability test, a total of 12 patients with a primary diag-
nosis of schizophrenia, currently undergoing in- or outpatient treatment at 
the Department for Psychosis, Aarhus University Hospital – Denmark, will 
be recruited. The team of raters will perform a total of at least 50 PANSS-6 
ratings via SNAPSI. All raters will conduct the SNAPSI at least once. As a 
measure of inter-rater reliability, we will calculate the Intraclass Correlation 
Coefficient based on the 50 PANSS-6 ratings.
Results: The results of the inter-rater reliability test will be available in 
January 2018 and presented at the SIRS 2018 conference.
Discussion: If  the results of the inter-rater reliability test are satisfactory, 
we will conduct a clinical validation of PANSS-6. In this study we will 
test whether PANSS-6 ratings obtained using the SNAPSI correspond to 
PANSS-6 ratings extracted from independent PANSS-30 ratings obtained 
using the SCI-PANSS. If  this is the case, PANSS-6 ratings obtained using 
the SNAPSI will facilitate valid measurement-based care of schizophrenia 
in clinical practice.
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Background: Repetitive transcranial magnetic stimulation (rTMS) applied 
to the left frontal lobe is discussed to be a promising add-on treatment for 
negative symptoms in schizophrenia. The Positive and Negative Syndrome 
Scale (PANSS) has been used as outcome parameter in several previous 
rTMS trials, but studies focusing on PANSS factor analyses are lacking.
For this purpose, we used the available PANSS data of the ‘rTMS for the 
Treatment of Negative Symptoms in Schizophrenia’ (RESIS) trial to calcu-
late different literature-based PANSS factors and to re-evaluate the impact 
of rTMS on negative symptoms in this trial.
Methods: In an exploratory re-analysis of published data from the RESIS 
study (Wobrock et al. 2015), we tested the impact of rTMS applied to the 
left dorsolateral prefrontal cortex on two PANSS factors for negative symp-
toms in psychotic disorders as well as on a PANSS five-factor consensus 
model intending to show that active rTMS treatment improves PANSS neg-
ative symptom subscores.
Results: In accordance to the original analysis, all PANSS factors showed 
an improvement over time in the active and, to a considerable extent, also 
in the sham rTMS group. However, comparing the data before and directly 
after the rTMS intervention, the PANSS excitement factor improved in the 
active rTMS group significantly more than in the sham group, but this find-
ing did not persist if  follow-up data were taken into account. These addi-
tional analyses extend the previously reported RESIS trial results showing 
unspecific improvements in the PANSS positive subscale in the active rTMS 
group.
Our PANSS factor-based approach to investigate the impact of prefrontal 
rTMS on different negative symptom domains confirmed no overall benefi-
cial effect of the active compared to sham rTMS.
Discussion: This secondary analysis of the RESIS trials has several limita-
tions. First of all, the analysis of the primary endpoint was negative [24] and 
all subsequent secondary analyses showing a positive effect of the interven-
tion (here: change in PANSS excitement factor) are of limited statistical 
power and therefore subject to uncertainty. On the other hand, our analyses 
confirm the negative finding of the original publication extends this finding 
to a broader negative symptom definition. Moreover, the new analysis pro-
vides a possible, but hypothetical explanation for the previously described 
effect of active rTMS on PANSS positive subscale. Of course, many other 
PANSS factor models are available and in pharmacological research the 
Marder factors [23, 35] have particular significance. However, the here used 
five-factor consensus model [21] includes the Marder factor results and our 
negative symptom factors overlaps with those factors. Another limitation 
is that it may be possible that our sham stimulation (coil tilted over one 
wing at an angle of 45°[24]) may still have been slightly biologically active 
as discussed elsewhere [24].
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Background: Motivation deficits are among the strongest determinants 
of reduced functioning and quality of life in people with schizophrenia. 
Mobile interventions are a promising approach to improving these deficits 
because they can provide frequent cues and reinforcements to support goal-
directed behavior in daily life. The objective of this study is to assess the 
initial feasibility/acceptability and effectiveness of Mobile Enhancement of 
Motivation in Schizophrenia (MEMS), a personalized mobile text message 
intervention, compared to a goal-setting alone intervention.
Methods: Fifty-six participants with a schizophrenia-spectrum disorder 
have been enrolled in this ongoing controlled pilot study. Twenty-seven par-
ticipants have been randomized to MEMS, while 29 participants have been 
randomized to the goal-setting alone condition. Participants in both groups 
set individualized recovery goals to complete over an 8-week period. Those 
in the MEMS group also receive three sets of personalized, interactive text 
messages each weekday to reinforce and cue goal completion. Blinded assess-
ments are conducted before and after the 8-week period and include validated 
measures of motivation, quality of life, and functioning. Goal attainment 
and self-reported satisfaction with MEMS are also assessed.
Results: To date, 36 participants (n  =  18 in each group) have completed 
both baseline and follow-up assessments. Initial results suggest that relative 
to the goal-setting alone group, the MEMS group demonstrated signifi-
cantly greater improvements in clinician-rated motivation (F(1, 33) = 7.14, 
p =  .01; between-group d =  .89). Specifically, the MEMS group demon-
strated significantly higher clinician-rated motivation after 8 weeks (within-
group d = .62), while clinician-rated motivation remained the same in the 
goal-setting alone group (within-group d = -.02). Across both groups, par-
ticipants also significantly improved on clinician-rated functioning over 
time (t(35) = -2.56, p = .02, d = .43), but there was no difference between the 
two groups (F(1, 33) = .01, p = .94; between-group d = .03). No improve-
ment on self-reported quality of life was observed in either group or across 
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the full sample. The MEMS group reported strong satisfaction with the 
text-messages. Recruitment has been completed, and analyses from the full 
sample will be ready to present at the meeting.
Discussion: Initial results indicate that MEMS is acceptable and may suc-
cessfully improve motivation in people with schizophrenia-spectrum disor-
ders. However, additional analyses with the full sample are needed to more 
rigorously test the feasibility and effectiveness of MEMS.
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Background: Cognitive impairment is a core feature of schizophrenia, which limits 
functions of individuals with schizophrenia and negatively influences their qual-
ity of life (Green, 1993; Green et al, 2000; Heaton et al., 2001; Heinrichs, 1998). 
While pharmacological treatment is known to have a limited effect on impaired 
cognition in schizophrenia (Marder, 2006; Rund and Borg, 1999; Elie et  al., 
2010), a majority of literature has concluded that cognitive remediation(CR) 
produces small to moderate improvements (McGurk et al., 2007; Wykes et al., 
2011). As the smartphone user population continues to increase, the effective-
ness of CR based on mobile devices have started to be studied. While CR is 
effective in improving cognitive deficit, treatment adherence and engagement of 
participants in the real world setting is known to be poor compared to laboratory 
setting. Thus, in the current randomized controlled study, we aimed to investigate 
whether motivational intervention would enhance motivation, treatment adher-
ence and neurocognitive function of individuals with schizophrenia.
Methods: All subjects participated in a group-based CR using mobile appli-
cation (mCR) twice a week for five weeks, and were given opportunity to 
practice voluntarily outside the treatment sessions. While CR only group 
participated in usual CR with Q&A sessions, experimental group partici-
pated CR sessions integrated with motivational intervention. For motiva-
tional enhancement (ME), we employed principles (e.g., goal setting, linking 
of CR with life goals, etc) of the bridging group (Medalia, Revheim, & 
Herlands, 2009) along with key aspects of motivational interviewing (e.g., 
open end questions, affirmation, reflect, and summary). We hypothesized 
that compared to CR only group, CR+ME group would show higher levels 
of intrinsic motivation, attendance rate and extra voluntary training hours, 
and greater improvement in cognitive functions.
Results: We are undergoing the current project, and a total of 14 partici-
pants were randomly assigned to either CR+ME (n=8) or CR only (n=5). 
Among 14 participants, two participants dropped out (n=1 experimental 
group and n=1 control group).
Independent sample t-test were used to compare scores of demographics 
and clinical characteristics between groups, and no differences were found 
except for the PANSS excitement subscale (t = 2.91, P < .05) at the time of 
pre-treatment. Due to a small sample, we conducted paired sample t-tests 
to examine whether there was a significant difference between the pre and 
post-test for two groups, respectively. The paired t-test revealed improve-
ments in coding, TMT-B, logical memory I and K-AVLT immediate recall 
performances of CR+ME (t=-2.92, p < .01; t=-3.65, p < .05; t=-3.20, 
p < .05; t=-2.89, p < .05), but not CR only. In addition, there were pre 
and post-treatment differences in motivation variables (MSQ) for CR+ME. 
Comparing task related motivational level of first session to the final 10th 
session, CR+ME showed increased identified regulation(IR) score of MSQ 
and decreased external regulation(ER) score (IR=22.3(3.2), 23.5(3.7); 
ER= 10.67 (3.88), 6.67 (3.08)).
Discussion: We conclude that ME is promising to further enhance neuro-
cognitive and motivational outcomes of mCR. The data collection process 
is expected to be completed in late January 2018, and the results will be 
accordingly updated by the time of presentation at SIRS 2018. Limitations 
and future directions will be discussed.
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Background: Recently, the efficacy of a novel virtual reality based cogni-
tive behavior therapy (VR-CBT) for paranoia was demonstrated. Cognitive 
biases, cognitive limitations, negative schematic beliefs and safety behavior 
have been associated with paranoid ideations and delusions. It is unknown 
whether VR-CBT affects these associated factors, and how changes in these 
factors relate to changes in paranoid ideation.
Methods: In this multi-center randomized controlled trial patients with a 
psychotic disorder and paranoia were randomized to VR-CBT (n = 58) or 
treatment as usual (TAU; n = 58). VR-CBT consisted of maximally sixteen 
60-minute individual therapy sessions. Paranoia, safety behavior, schematic 
beliefs, cognitive biases and limitations were assessed at baseline, post-treat-
ment (at three months) and follow-up (at six months). Mixed model analyses 
were conducted to study treatment effects. Mediation analyses were performed 
to explore putative working mechanisms by which VR-CBT reduced paranoia.
Results: VR-CBT, but not TAU, led to reductions in jumping to conclu-
sions, attention for threat bias and social cognition problems. Schematic 
beliefs remained unaffected. The effect of VR-CBT on paranoia was medi-
ated by reductions in safety behavior and social cognition problems.
Discussion: VR-CBT affects multiple mechanisms that are associated with 
paranoid ideation. Although maintaining factors of paranoia are likely to 
influence each other, targeting safety behavior and social cognitive prob-
lems seems effective in breaking the vicious circle of paranoia.
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Background: Cognitive impairment is the most important feature of schizo-
phrenia that leads to severe social and functional disability. Improving neu-
rocognitive physiopathologic aspect of schizophrenia is a current challenge 
to identify the pathway to develop goal directed clinical interventions in prac-
tice. In the current study we investigated the effect of raloxifine as a selective 
estrogen modulator and isradipine as a voltage gated L type calcium channel 
blocker on the enhancement of schizophrenic patients’ cognitive deficits.
Methods: We designed a double blind randomized, parallel, placebo con-
trolled clinical trials. 60 patients with schizophrenia randomized in 3 spe-
cific groups. The first group received isradipine 5 mg, the second raloxifine 
60 mg and the third placebo for 6 consequent weeks, in the same shape cap-
sules, 2 times a day, alongside treatment with the conventional antipsychot-
ics. The initial and final lab tests, ECG, as well as cognitive tests in specific 
domains such as attention, processing speed, executive function and verbal 
memory were carried out.
Results: Our findings, revealed a remarkable association between adjunctive 
treatment of raloxifine in verbal memory deficits. moreover, isradipine treat-
ment indicated significant improvement relative to placebo in verbal memory as 
well as attention dysfunction in some variables of the Stroop test. However, no 
effect was observed in processing speed and executive function deficits.
Discussion: The study provides the first evidence to our knowledge, which 
isradipine as a novel therapy was associated with improvement in verbal 
